CEO Tim Craggs emphasizes the aim at Exciting Instruments: "Our vision at Exciting Instruments is to bring the power of single-molecule detection to every academic and pharma lab across the globe." This statement underscores their mission to make advanced detection technology widely accessible.
COO Robert Bell highlights the foundational role of their expertise, stating, "Our team's deep expertise and passion have been instrumental in achieving remarkable early traction across the US and Europe." This reflects their confidence in expanding their technology's reach.
Dr. Timothy Craggs articulates the transformative potential of their approach: "Single-molecule spectroscopy is a powerful technique that could lead to new discoveries in biophysics, life sciences, drug development and diagnostics." This perspective frames their technology as a pivotal advancement.
The article emphasizes the investment's purpose, noting that it will allow Exciting Instruments to "accelerate the development of our technology, focusing on enhancing the speed, simplicity, and impact of single-molecule detection for researchers and industry professionals." This points to a significant scalability of their platform.
Collection
[
|
...
]